For: | Fouad YM, Mostafa I, Yehia R, El-Khayat H. Biomarkers of Barrett's esophagus. World J Gastrointest Pathophysiol 2014; 5(4): 450-456 [PMID: 25400988 DOI: 10.4291/wjgp.v5.i4.450] |
---|---|
URL: | https://www.wjgnet.com/2150-5330/full/v5/i4/450.htm |
Number | Citing Articles |
1 |
Lucia Marseglia, Sara Manti, Gabriella D’Angelo, Eloisa Gitto, Carmelo Salpietro, Antonio Centorrino, Gianfranco Scalfari, Giuseppe Santoro, Pietro Impellizzeri, Carmelo Romeo. Gastroesophageal reflux and congenital gastrointestinal malformations. World Journal of Gastroenterology 2015; 21(28): 8508-8515 doi: 10.3748/wjg.v21.i28.8508
|
2 |
Mark Pusung, Sebastian Zeki, Rebecca Fitzgerald. Stem Cells, Pre-neoplasia, and Early Cancer of the Upper Gastrointestinal Tract. Advances in Experimental Medicine and Biology 2016; 908: 237 doi: 10.1007/978-3-319-41388-4_12
|
3 |
Luke Taylor, Hani Naeem Alastal, Ashraf Rasheed. Molecular biomarkers of progression from Barrett’s esophagus to esophageal adenocarcinoma. Frontiers in Gastroenterology 2023; 2 doi: 10.3389/fgstr.2023.1007456
|
4 |
Zhen Li, Qianlan Yao, Songjian Zhao, Zhen Wang, Yixue Li. Protein coding gene CRNKL1 as a potential prognostic biomarker in esophageal adenocarcinoma. Artificial Intelligence in Medicine 2017; 76: 1 doi: 10.1016/j.artmed.2017.01.002
|
5 |
Gemma Maddalo, Matteo Fassan, Romilda Cardin, Marika Piciocchi, Filippo Marafatto, Massimo Rugge, Giovanni Zaninotto, Caterina Pozzan, Carlo Castoro, Alberto Ruol, Alessandra Biasiolo, Fabio Farinati. Squamous Cellular Carcinoma Antigen Serum Determination as a Biomarker of Barrett Esophagus and Esophageal Cancer. Journal of Clinical Gastroenterology 2018; 52(5): 401 doi: 10.1097/MCG.0000000000000790
|
6 |
Aurada Cholapranee, Arvind J Trindade. Challenges in Endoscopic Therapy of Dysplastic Barrett’s Esophagus. Current Treatment Options in Gastroenterology 2019; 17(1): 32 doi: 10.1007/s11938-019-00215-8
|
7 |
PAATA MESHVELIANI, GIORGI DIDAVA, GIA TOMADZE, GEORGE BURKADZE. CRITICAL REVIEW: BARRETS OESOPHAGUS – METAPLASIA – DYSPLASIA – MALIGNANT TRANSFORMAYION PHENOTYPICAL CHARACTERISTICS AND PROGRESSION MARKERS. EXPERIMENTAL & CLINICAL MEDICINE GEORGIA 2022; doi: 10.52340/jecm.2022.718
|
8 |
Ishaan Maitra, Ravindra Sudhachandra Date, Francis Luke Martin. Towards screening Barrett’s oesophagus: current guidelines, imaging modalities and future developments. Clinical Journal of Gastroenterology 2020; 13(5): 635 doi: 10.1007/s12328-020-01135-2
|
9 |
Chidi Amadi, Piers Gatenby. Barrett’s oesophagus: Current controversies. World Journal of Gastroenterology 2017; 23(28): 5051-5067 doi: 10.3748/wjg.v23.i28.5051
|
10 |
Dabiao Liu. LYN, a Key Gene From Bioinformatics Analysis, Contributes to Development and Progression of Esophageal Adenocarcinoma. Medical Science Monitor Basic Research 2015; 21: 253 doi: 10.12659/MSMBR.895463
|
11 |
Aleksandra M. Urbanska, Selvarangan Ponnazhagan, Masoud Mozafari. Pathology, Chemoprevention, and Preclinical Models for Target Validation in Barrett Esophagus. Cancer Research 2018; 78(14): 3747 doi: 10.1158/0008-5472.CAN-18-0206
|
12 |
Sathisha Upparahalli Venkateshaiah, Chandra Sekhar Yadavalli, Hemanth Kumar Kandikattu, Sandeep Kumar, Lokanatha Oruganti, Anil Mishra. Molecules involved in the development of Barrett’s esophagus phenotype in chronic eosinophilic esophagitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2022; 323(1): G31 doi: 10.1152/ajpgi.00321.2021
|
13 |
Young Choi, Andrew Bedford, Simcha Pollack. The Aberrant Expression of Biomarkers and Risk Prediction for Neoplastic Changes in Barrett’s Esophagus–Dysplasia. Cancers 2024; 16(13): 2386 doi: 10.3390/cancers16132386
|
14 |
Monjur Ahmed. Barrett’s Oesophagus in 2016. EMJ Gastroenterology 2016; : 116 doi: 10.33590/emjgastroenterol/10311314
|